Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $476.95, signifying a +1.45% move from its prior day's close.

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $470.13, denoting a +2.54% move from the preceding trading day.

Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an announcement. Vortex Energy Corp. has received government approval to conduct an Ambient Noise ...

Valued at a market cap of $117.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company that ...

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Investors in Vertex Pharmaceuticals, Inc. (Symbol: VRTX) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Learn about the executive team and board of directors at Vertex Pharmaceuticals Inc (VRTX:XNAS) and review their bios and compensation over the latest fiscal years.

Vertex Pharmaceuticals Incorporated VRTX reported second-quarter 2022 adjusted earnings per share of $3.60, which beat the Zacks Consensus Estimate of $3.48. The company recorded earnings of 17 ...